Modifying Effect of Dual Antiplatelet Therapy on Incidence of Stent Thrombosis According to Implanted Drug-Eluting Stent Type

Study Questions:

What is the putative modifying effect of dual antiplatelet therapy (DAPT) use on the incidence of stent thrombosis at 3 years in patients randomized to Endeavor zotarolimus-eluting stent (E-ZES) or Cypher sirolimus-eluting stent (C-SES)?